Condition
Regurgitation, Aortic
Total Trials
4
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Enrolling By Invitation1
Active Not Recruiting1
Terminated1
Unknown1
Clinical Trials (4)
Showing 4 of 4 trials
NCT03520101Not ApplicableActive Not Recruiting
Comparison of the Balloon-Expandable Edwards Valve and Self-Expandable CoreValve Evolut R or Evolut PRO System for the Treatment of Small, Severely Dysfunctional Surgical Aortic Bioprotheses. The 'LYTEN' Trial
NCT05714293Not ApplicableEnrolling By Invitation
CT-evaluation of Coronary Ostia Height After Surgical Aortic Valve Replacement.
NCT04370041Not ApplicableTerminated
Dokimos Plus Aortic Valve Implant in 80 Patients Diagnosed With a Heart Valve Disease and Requiring Valve Replacement
NCT04047082Unknown
Online Videodensitometric Assessment of Aortic Regurgitation in the Cath-Lab
Showing all 4 trials